The growing demand for controlled immunological research and therapeutic design has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using various expression methods, including microbial hosts, higher cell lines, and insect repli